drugset / Trial / NCT04456803
Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of ferric citrate tablet in the control of serum phosphorus levels in patients with chronic kidney disease undergoing hemodialysis.
Timeline
- Start
- 2019-05-24
- Primary completion
- 2022-09-13
- Completion
- 2022-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferric Citrate | Unknown | 250 mg | — |
| Comparator | sevelamer | Other / unclassified | 800 mg | — |